File:Immunotherapy + Durvalumab + Pembrolizumab + Ipilimumab + Atezolizumab mechanism of action.jpg
Appearance
Size of this preview: 800 × 443 pixels. Other resolutions: 320 × 177 pixels | 640 × 355 pixels | 1,024 × 568 pixels | 1,694 × 939 pixels.
Original file (1,694 × 939 pixels, file size: 164 KB, MIME type: image/jpeg)
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 03:15, 10 November 2021 | 1,694 × 939 (164 KB) | Sannecola | Uploaded a work by Nicola J. Nasser, Miguel Gorenberg, Abed Agbarya 3ORCID from Adapted from: First line Immunotherapy for Non-Small Cell Lung Cancer. Pharmaceuticals 2020, 13(11), 373; https://doi.org/10.3390/ph13110373 with UploadWizard |
File usage
The following 2 pages use this file:
Global file usage
The following other wikis use this file:
- Usage on ja.wikipedia.org
- Usage on zh-min-nan.wikipedia.org